Post by Olivia Hough

Clinical Development Manager at Traferox Technologies Inc.

I'm incredibly excited to share that the TorEx Lung Perfusion System has received FDA Premarket Approval. My journey with TorEx has come full circle, from performing countless EVLPs during my PhD to supporting its approval journey since joining Traferox. Today, that same technology has received FDA approval - marking an important step toward helping more donor lungs be assessed and considered for transplantation. I'm incredibly proud to be part of such an amazing team and grateful to the mentors, collaborators, and colleagues who helped bring this technology from research to clinical practice. Congratulations to everyone who helped make this milestone possible!

Post content